Cytosorbents (CTSO) Exchange Rate Effect (2013 - 2026)
Cytosorbents (CTSO) posted Exchange Rate Effect of -$228000.0 for Q1 2026, down 116.88% on a QoQ basis from $1.4 million in Q4 2025, and down 914.29% year-over-year from $28000.0 in Q1 2025.
Cytosorbents (CTSO) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Cytosorbents' Exchange Rate Effect history runs 14 years deep, the most recent figure standing at -$228000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 914.29% year-over-year to -$228000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 2065.53% YoY) and the FY2025 annual result came in at $1.5 million, up 1852.94% from the prior year.
- Exchange Rate Effect was -$228000.0 for Q1 2026 at Cytosorbents, down from $1.4 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.4 million in Q4 2025 and bottomed at -$228000.0 in Q1 2026.
- A 5-year average of $47900.4 and a median of -$35003.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 3150.12% — and 2025, when it jumped 1374.53%.
- Cytosorbents' Exchange Rate Effect stood at $138734.0 in 2022, then slumped by 171.05% to -$98564.0 in 2023, then decreased by 7.54% to -$106000.0 in 2024, then soared by 1374.53% to $1.4 million in 2025, then plunged by 116.88% to -$228000.0 in 2026.
- Business Quant data shows CTSO's Exchange Rate Effect at -$228000.0 in Q1 2026, $1.4 million in Q4 2025, and -$146000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -2.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.66 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | -228,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -228,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Dec 31, 2025 | 1.35 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | -146,000.00 |
| Sep 30, 2025 | -146,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | -106,000.00 |
| Dec 31, 2024 | -106,000.00 |
| Sep 30, 2024 | 85,000.00 |
| Sep 30, 2024 | 85,000.00 |
| Jun 30, 2024 | -69,782.00 |
| Jun 30, 2024 | -69,782.00 |
| Mar 31, 2024 | 5,782.00 |
| Mar 31, 2024 | 5,782.00 |
| Dec 31, 2023 | -98,564.00 |
| Dec 31, 2023 | -98,564.00 |